Lethal effects and cardiovascular effects of purified a- and 6-toxins from clostridium perfringens

Journal of Infectious Diseases

Volumn 157, Issue 2, 1988, Pages 272-279

  Stevens, Dennis L ^a,a,b   Troyer, Brett E ^a,b   Merrick, Daniel T ^a,b   Mitten, Joanne E ^a,b   Olson, Richard D ^a,b  

^a Boise VA Medical Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOXIN;

ANIMAL EXPERIMENT; CARDIOVASCULAR RESPONSE; CLOSTRIDIUM PERFRINGENS; COMPLICATION; FATALITY; HUMAN; LETHALITY; MOUSE; RABBIT; SHOCK; SHORT SURVEY;

ANIMAL; BACTERIAL TOXINS; BLOOD PRESSURE; CARDIAC OUTPUT; CLOSTRIDIUM PERFRINGENS; FEMALE; GAS GANGRENE; HEART; HEART RATE; HEMODYNAMICS; HEMOLYSINS; MALE; MICE; RABBITS; SHOCK, SEPTIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0023930231     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/157.2.272     Document Type: Article

References (33)

1. Smith LDS. Clostridium perfringens. In: Smith LDS, ed. The pathogenic anaerobic bacteria. Springfield, 111: Charles C. Thomas, 1975:115-76
2. Finegold SM, George WL, Mulligan ME. Anaerobic infections. Part I. DM 1985;31:50-7
3. MacLennan JD. The histotoxic clostridial infections of man. Bacteriologic Reviews 1962;26:177-276
4. Darke SG, King AM, Slack WK. Gas gangrene and related infection: Classification, clinical features and aetiology, managment and mortality. A report of 88 cases. Br J Surg 1977;64:104-12
5. McNee JW, Dunn JS. The method of spread of gas gangrene into living muscle. Br Med J [Clin Res] 1917;1:727-9
6. Robb-Smith AHT. Tissue changes induced by Cl. welchii type A filtrates. Lancet 1945;2:362-8
7. Strunk SW, Smith CW, Blumberg JM. Ultrastructural studies on the lesion produced in skeletal muscle fibers by crude type A Clostridium perfringens toxin and its purified alpha fraction. Am J Pathol 1967;50:89-107
8. Möllby R, Nord C-E, Wadström T. Biological activities contaminating preparations of phospholipase C (a-toxin) from Clostridium perfringens. Toxicon 1973;11:139-47
9. 14C-labelled toxin of Clostridium perfringens. J Bacteriol 1961;82:275-83
10. Smith LDS. Virulence factors of Clostridium perfringens. Rev Infect Dis 1979;1:254-60
11. Gantely OH, Merchant DJ, Bohr DF. The relationship of toxic fractions of a filtrate of Clostridium perfringens type A to the pathogenesis of clostridial myonecrosis. J Exp Med 1955;101:605-15
12. Evans DG. The in-vitro production of a-toxin, 0 haemolysin and hyaluronidase by strains of Cl. welchii type A, and the relationship of in-vitro properties to virulence for guinea- pigs. Journal of Pathology and Bacteriology 1945;57:75-85
13. Bullen JJ. Role of toxins in host-parasite relationships. In: Montie TC, Kadis S, Ajl SJ, eds. Microbial toxins. Vol 2. London: Academic Press, 1970:233-75
14. Ispolatovskaya MV. Type A Clostridium perfringens toxin. In: Kadis S, Montie TC, Ajl SJ, eds. Microbial Toxins. Vol 2A. New York: Academic Press, 1972:109-58
15. Pope A, Zamecnik PC, Aub JC, Brues AM, Dubos RJ, Nathanson IT, Nutt AL. The toxic factors in experimental traumatic shock. VI. The toxic influence of the bacterial flora, particularly Clostridium welchii in exudates of ischemic muscle. J Clin Invest 1945;24:856-63
16. Ellrodt AG, Riedinger MS, Kimchi A, Berman DS, Maddahi J, Swan HJC, Murata GH. Left ventricular performance in septic shock: Reversible segmental and global abnormalities. Am Heart J 1985;110:402-9
17. Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985;76:1539-53
18. Stevens DL, Maier KA, Laine BM, Mitten JE. Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens. J Infect Dis 1987;155:220-8
19. Smyth CJ, Arbuthnott JP. Properties of Clostridium perfringens (welchii) type A a-toxin (phospholipase C) purified by electrofocusing. J Med Microbiol 1974;7:41-66
20. Smyth CJ. The identification and purification of multiple forms of 0-haemolysin (0-toxin) of Clostridium perfringens type A. J Gen Microbiol 1975;87:219-38
21. Mollby RC, Wadstrom T. Purification of phospholipase C (alpha-toxin) from Clostridium perfringens. Biochim Bio- phys Acta 1973;321:569-84
22. Hartwigk H, Chenitir H. Nachweis des alpha-toxins von Cl. Welchii durch testblattchen. Zentralbl Veterinarmed [B] 1969;16:266-74
23. Kurioka S, Matsuda M. Phospholipase C assay using p-nitrophenylphosphorylcholine together with sorbitol and its application to studying the metal and detergent requirement of the enzyme. Anal Biochem 1976;75:281-9
24. Layne E. Spectrophotometric and turbidimetric methods for measuring proteins. In: Colowick SP, Kaplan ND, eds. Methods in enzymology. Vol 3. New York: Academic Press, 1957:447-54
25. Reed LJ, Meunch H. A simple method of estimating fifty per cent endpoints. American Journal of Hygiene 1938; 27:493-7
26. Li JCR. Test of specific hypotheses in the analysis of variance. In: Li JCR, ed. Statistical inference. Vol 1. Ann Arbor, Mich: Edwards Brother, 1964:245-78
27. Soda S, Ito A, Yamamoto A. Production and properties of q-toxin of Clostridium perfringens with special reference to lethal activity. Jpn J Med Sci Biol 1976;29:335-49
28. Lynch KL, Moskowitz M. Effects of chelates in chemotherapy of experimental gas-gangrene toxemia. J Bacteriol 1968;96:1925-30
29. Sakurai J, Oshita Y, Fujii Y. Effect of Clostridium perfringens alpha toxin on the cardiovascular system of rats. Tox- icon 1985;23:905-12
30. Regal JF, Shideman FE. The effect of phospholipase C on the responsiveness of cardiac receptors. I. Inhibition of the adrenergic inotropic response. J Pharmacol Exp Ther 1980;214:282-90
31. 2* permeability of cardiac sarcolemmal vesicles. J Biol Chem 1983;258: 5905-10
32. Whatley RE, Stevens DL, Zimmerman GA, McIntyre TM, Prescott SM. Clostridium perfringens theta toxin induces endothelial cells to produce platelet-activating factor [abstract]. Clin Res 1987;35:495A.
33. Levi R, Burke JA, Guo ZG, Hattori Y, Hoppens CM, McManus LM, Hanahan DJ, Pinckard RN. Acetyl glyceryl ether phosphorylcholine (AGEPC): A putative mediator of cardiac anaphylaxis in the guinea pig. Circ Res 1984; 54:117-24.